Skip to content

Does homeopathic medicine Lactuca virosa have galactagogue activity in lactating women?

Does homeopathic medicine Lactuca virosa have galactagogue activity in lactating women? A Randomized, Placebo-Controlled, Double-Blind Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060522
Enrollment
198
Registered
2023-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Lactuca virosa (homeopathic remedy): Known pharmacopoeial preparations of the homeopathic remedy of different potencies (30/200) in globules Control Intervention1: Identical Placebo: K

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mother who delivers a singleton child after 37 weeks of gestation via cesarean section and has given informed consent to participate in the study trial. 2. Mother willing to breastfeed and willing to be in the hospital facility for 7 days post-delivery.

Exclusion criteria

Exclusion criteria: 1. Mothers having breast abnormalities: Hypoplastic breasts, mastitis, history of breast surgery, breast cancer abnormality of nipples, etc. 2. Mothers suffering from a chronic debilitating disease or endocrine disorder like known cases of diabetes, hypertension, hypothyroidism, Prolactin-releasing pituitary tumor, Sheehan’s syndrome, Postpartum hemorrhage or infection, HIV, liver disorders, etc. 3. Mothers who are already on medications with dopaminergic or anti-dopaminergic activity or those which affect prolactin levels. 4. Mothers suffering from psychological disorders like chronic depression, psychosis, postnatal depression, etc, and show the inability to comply with the study protocol 5. Mothers who are active cigarette smokers and consume alcohol. 6. Factors related to the newborn child which may affect/prevent the sucking of the breast e.g. tongue tie, cleft palate, congenital heart disease, or condition which requires/leads to separating mother and child.

Design outcomes

Primary

MeasureTime frame
Milk quantity per feed per dayTimepoint: Daily

Secondary

MeasureTime frame
Adverse maternal side effectTimepoint: Daily;Maternal Mental health on Edinburgh Postnatal Depression Scale (EPDS)Timepoint: At day 0 and day 7;Number of women attaining adequate lactationTimepoint: Daily;Prolactin levelsTimepoint: At day 0, day 3 and day 7;Requirement of formula feedTimepoint: Daily;Requirement of GalactagoguesTimepoint: Daily;Time taken to attain the adequate volume of milk productionTimepoint: Daily

Countries

India

Contacts

Public ContactDr Navin Pawaskar

CENTRAL COUNCIL FOR RESEARCH IN HOMOEOPATHY

drdnayak@gmail.com9873404012

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026